SYNAPTOGENIX INC.
8.05 $
"Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1
and its analogues to discover and develop targeted, novel regenerative therapeutics
for neurodegenerative diseases and developmental disorders. Our experience and passion
for novel drug therapies have enabled us to develop a pipeline that includes synaptogenic treatment
approaches for serious and difficult-to-treat diseases such as Alzheimer’s disease, Fragile X Syndrome,
MS, Parkinsons, Traumatic Brain Injury, Stroke, and Autism Spectrum Disorders."
www.synaptogen.com/
8.05 $
"Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1
and its analogues to discover and develop targeted, novel regenerative therapeutics
for neurodegenerative diseases and developmental disorders. Our experience and passion
for novel drug therapies have enabled us to develop a pipeline that includes synaptogenic treatment
approaches for serious and difficult-to-treat diseases such as Alzheimer’s disease, Fragile X Syndrome,
MS, Parkinsons, Traumatic Brain Injury, Stroke, and Autism Spectrum Disorders."
www.synaptogen.com/
